E-drug: Agenda Workshop
Workshop on Intellectual Property, Health Care and
International Trade Agreements
May 7-8, 1998
Thursday, May 7
9:00 AM Opening Remarks by Ralph Nader and Introduction
9:30 AM Overview of Intellectual Property Issues and
Public Interest Considerations, as they relate to
Public Health and Research and Development
What are the available Mechanisms to Finance R&D?
Who makes policy?
10:30 AM Break
10:45 AM Discussion of specific IPR disputes
Scope of patents in health care
Standards for patent protection
Second use patents, evergreening of patents, and
Bolar provisions and other exemptions for medical
Patent terms and patent extensions
Health Registration Data
"unfair competition" protections
exclusive marketing rights
Sui Generis Database Legislation
Trademarks and Public Health.
12:00 PM Break for Lunch in Area Restaurants
1:30 PM Continue Discussion of Specific IPR disputes
3:30 PM Break
3:45 PM Continue Discussion of Specific IPR disputes
5:30 PM Conclusion of First Day
Friday, May 8
9:AM PM Continue Discussion of Specific IPR disputes
10:00 AM Economics of Drug Development
What does it really cost to develop new drugs?
Pricing of Government Funded Medical Inventions
Need to collect economic data
11:00 AM Break
11:15 AM WHO Resolution on Revised Drug Policy
12:00- 1:30 PM Lunch in area restaurants
1:30 PM Dialog with U.S. Government Policy Makers
3:00 PM Break
3:15 PM How do consumer and public health advocates
Organize? Next Steps
5:00 PM Concluding Comments
5:30 PM Conclusion
For more information, see http://www.cptech.org/may7-8
Consumer Project on Technology
P.O. Box 19367, Washington, DC 20036
firstname.lastname@example.org | http://www.cptech.org
voice 202.387.8030, fax 202.234.5176
Send mail for the `E-Drug' conference to `email@example.com'.
Mail administrative requests to `firstname.lastname@example.org'.
For additional assistance, send mail to: `email@example.com'.